You are here

  • Home
  • Archive
  • Volume 11, Issue 5
  • Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses

Article metrics

Article menu

This article has a correction. Please see:

Clinical/translational cancer immunotherapy
Original research
Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses

 

Online download statistics by month:

Online download statistics by month: May 2023 to July 2025

AbstractFullPdf
May 202346946970
Jun 202347748080
Jul 202322222453
Aug 202338138163
Sep 202314214263
Oct 202313413538
Nov 202321221646
Dec 202328228439
Jan 2024908957
Feb 2024969748
Mar 202411811854
Apr 202413213369
May 202410610956
Jun 202412612663
Jul 202410811044
Aug 2024707130
Sep 202477791235
Oct 2024848557
Nov 202410711459
Dec 202411511651
Jan 2025858737
Feb 202513213251
Mar 202510710759
Apr 202513313356
May 202510911080
Jun 2025444636
Jul 2025220
Total416041952594